(Q47581817)

4 February 2018

meta-analysis

0 references

title

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis (English)

1 reference

4 February 2018

0 references

0 references

1 reference

Ling Peng

1

1 reference

4 February 2018

Ping Zhan

2

1 reference

4 February 2018

Yun Zhou

3

1 reference

4 February 2018

Weijia Fang

4

1 reference

4 February 2018

Peng Zhao

5

1 reference

4 February 2018

Yulong Zheng

6

1 reference

4 February 2018

Nong Xu

7

1 reference

4 February 2018

publication date

23 June 2012

1 reference

4 February 2018

Molecular Biology Reports

published in

1 reference

4 February 2018

volume

39

1 reference

4 February 2018

issue

10

1 reference

4 February 2018

page(s)

9473-9484

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s11033-012-1812-8

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Recent patterns in gastric cancer: a global overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Systematic reviews of evaluations of prognostic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

The vascular endothelial growth factor family and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Constitutive and inducible expression and regulation of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Lymphangiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Vascular endothelial growth factor signaling pathways: therapeutic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

A role for VEGF as a negative regulator of pericyte function and vessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

No association of vascular endothelial growth factor-A (VEGF-A) and VEGF-C expression with survival in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Prognostic significance of vascular endothelial growth factor D in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1812-8

Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma

21 January 2018

1 reference

12 December 2020

Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer

1 reference

12 December 2020

Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma

1 reference

12 December 2020

Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.

1 reference

12 December 2020

Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer

1 reference

12 December 2020

Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer

1 reference

12 December 2020

Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center

1 reference

12 December 2020

Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer

1 reference

12 December 2020

Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers

1 reference

12 December 2020

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis

1 reference

12 December 2020

Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients

1 reference

12 December 2020

Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer

1 reference

12 December 2020

Urokinase‐type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer

1 reference

12 December 2020

Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer

1 reference

12 December 2020

Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer

1 reference

12 December 2020

10.1007/S11033-012-1812-8

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018